Nurix Therapeutics discovers drugs that harness the body’s natural process to control protein levels. Our drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells, as a unique therapeutic approach called targeted protein modulation to treat a broad range of diseases. Our focus is on developing targeted therapies to treat cancer including novel, small molecule immuno-oncology agents.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
October 26, 2020
October 14, 2020
October 6, 2020
January 11 - January 14, 2021
J.P. Morgan 39th Annual Healthcare Conference (JPM 2021)
December 1 - December 3, 2020
Piper Sandler 32nd Annual Healthcare Conference (Virtual)
November 16 - November 18, 2020
Stifel Virtual Healthcare Conference